Speech Discrimination for Fragile X Syndrome
Trial Summary
What is the purpose of this trial?
Individuals with Fragile X Syndrome show differences in how they understand and learn language from infancy. They frequently have lifelong delays in speech and language as well. In addition, they experience other auditory symptoms, including being very sensitive to certain sounds as well as being more sensitive than others to loud sounds. The underlying brain activity for sound perception and speech learning in Fragile X is not well understood, especially in the infant and toddler years. This study uses behavioral assessment of speech and language abilities, neuroimaging, and hearing tests to understand how speech and hearing are different in children with Fragile X Syndrome.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Speech discrimination, Speech Therapy, Auditory Training for Fragile X Syndrome?
Research indicates that individuals with Fragile X Syndrome have difficulties with auditory processing and speech sound processing, which can impact language development. Speech therapy and auditory training may help improve these areas by targeting the specific auditory and speech challenges identified in studies, such as impaired phonological processing and abnormal neural responses to sounds.12345
Is speech discrimination therapy safe for humans?
How does the treatment Speech Discrimination differ from other treatments for Fragile X Syndrome?
Speech Discrimination therapy focuses on improving the ability to distinguish and understand speech sounds, which is particularly important for individuals with Fragile X Syndrome who often have difficulties with language development and auditory processing. This approach is unique because it targets the specific auditory processing challenges associated with the syndrome, unlike other treatments that may not address these specific speech and language issues.123510
Eligibility Criteria
This trial is for infants with Fragile X Syndrome, a genetic condition that affects language and sound perception. It aims to understand how these children differ in speech understanding and hearing from an early age.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial assessment of speech and language abilities, neuroimaging, and hearing tests
Longitudinal Assessment
Participants undergo EEG/fNIRS and other assessments at multiple age points to track development
Follow-up
Participants are monitored for changes in auditory and language development
Treatment Details
Interventions
- Speech discrimination (Behavioural Intervention)